A detailed history of Elequin Capital LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Elequin Capital LP holds 288 shares of BBIO stock, worth $7,997. This represents 0.01% of its overall portfolio holdings.

Number of Shares
288
Previous 314 8.28%
Holding current value
$7,997
Previous $7,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$23.91 - $31.3 $621 - $813
-26 Reduced 8.28%
288 $7,000
Q2 2024

Aug 12, 2024

BUY
$23.0 - $31.04 $7,222 - $9,746
314 New
314 $7,000
Q2 2023

Aug 14, 2023

BUY
$13.29 - $18.01 $9,010 - $12,210
678 New
678 $11,000
Q3 2022

Nov 10, 2022

SELL
$7.94 - $12.36 $3,382 - $5,265
-426 Reduced 43.69%
549 $5,000
Q2 2022

Aug 11, 2022

BUY
$5.21 - $12.14 $479 - $1,116
92 Added 10.42%
975 $9,000
Q1 2022

May 16, 2022

BUY
$7.34 - $17.16 $6,481 - $15,152
883 New
883 $9,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.12B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Elequin Capital LP Portfolio

Follow Elequin Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elequin Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Elequin Capital LP with notifications on news.